Paige
Paige raises $45M Series C at $120M valuation
Quick Facts
Paige: Series C Funding Round
Paige has successfully raised $45M in Series C funding, reaching a valuation of $120M.
Company Overview
AI cancer diagnosis platform
Funding Details
The Series C round was led by Northpond Ventures, with participation from Goldman Sachs.
Company Information
- Headquarters: New York, NY
- Founded: 2017
- Employees: 100+
- Category: HealthTech
Investment
Paige plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Northpond Ventures: Verified investor in Series C
- Goldman Sachs: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
